Evidence map›Paper›PMID 42022244›Full record

ArticleCureus2026

Functional Outcomes After Holmium Laser Enucleation of the Prostate: Changes in the Urinary Flow Rate and Symptom Score During Short- and Mid-Term Follow-Up.

Jorge Martin Millet, Viviana Farrera Gonzalez, Eduardo Cruz Nuricumbo, Hugo De La Rosa Barrera

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jorge Martin MilletUrology, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan (HRAEPY), Merida, MEX.
Viviana Farrera GonzalezUrology, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan (HRAEPY), Merida, MEX.
Eduardo Cruz NuricumboEndourology, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan (HRAEPY), Merida, MEX.
Hugo De La Rosa BarreraUrology, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan (HRAEPY), Merida, MEX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe objective of this study is to assess changes in the maximum urinary flow rate and symptom score in patients undergoing holmium laser enucleation of the prostate during short- and mid-term follow-up. MATERIALS AND

methodsThis retrospective longitudinal study included patients treated with holmium laser enucleation of the prostate between January 2021 and December 2022 at a tertiary referral center. The urinary flow rate and symptom score were evaluated before surgery and at 1, 3, 6, 12, 18, and 24 months after the procedure. Comparisons between baseline and postoperative values were performed using appropriate statistical tests, with statistical significance set at p < 0.05.

resultsThe analysis included 121 patients with a mean age of 69.9 ± 8.0 years. The mean urinary flow rate increased from 10.29 ± 5.27 mL/s before surgery to 20.01 ± 10.94 mL/s at one month, with continued improvement reaching 25.83 ± 10.70 mL/s at 24 months. The mean symptom score decreased from 20.29 ± 9.25 at baseline to 9.12 ± 6.66 at one month, with further reduction to 5.65 ± 4.16 at 12 months. The overall postoperative complication rate was 13.9%, and urinary incontinence decreased from 7.4% in the early postoperative period to 0.8% at 12 months.

conclusionsIn this cohort, holmium laser enucleation of the prostate was associated with sustained improvement in urinary flow and symptom burden, supporting its role as a durable surgical option for benign prostatic hyperplasia.

Indexed as

benign prostatic hyperplasia (bph)holmium laser enucleation of the prostate (holep)international prostate symptom score (ipss)lower urinary tract symptomsqmax

Identifiers

PMID42022244
PMCPMC13099146

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.